Growth Hormone Peptides: A Research Overview
An overview of peptides studied in research for interactions with growth hormone pathways.
Last updated: 24 April 2026
What are growth-hormone peptides?
Growth-hormone (GH) peptides are compounds studied in research for their potential effects on growth-hormone secretion and related metabolic pathways. Some are endogenous releasing factors; others are synthetic variants designed to interact with GH regulation.
This category includes both GH-releasing peptides and inhibitors studied in research contexts.
Regulatory status in Australia
In Australia, GH and GH-related peptides are scheduled substances. They are restricted under the Therapeutic Goods Act and the Poisons Standard. Supply without appropriate licensing is illegal.
This regulatory status reflects the potency of GH as a hormone and the need for medical oversight.
Research evidence
GH peptides have been investigated in animal models and human trials for various applications. Clinical evidence exists for some compounds; others remain largely in preclinical research. Research contexts are distinct from approved clinical use.
Assessing quality of evidence
When evaluating GH peptide research, examine: is the evidence from cell models, animals, or humans? What is the sample size of human studies? Are results consistent across independent research groups? Single studies or small samples are weaker evidence.